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Calmodulin-dependent glycogen synthase kinase from rabbit skeletal muscle and calmodulin-dependent 
protein kinase-II from rat brain were found to have remarkably similar substrate specificities. Both protein 
kinases phosphorylated synapsin-I, glycogen synthase, smooth muscle myosin light chains, histone Hl and 
acetyl-CoA carboxylase at the same relative rates. Site-2 of glycogen synthase was preferentially 
phosphorylated by both enzymes, followed by a slower phosphorylation of site-lb. Each protein kinase 
catalysed a 2-fold activation of tryptophan 5-monooxygenase. Calmodulin-dependent protein kinase-II 
and glycogen synthase kinase exhibited similar immunological cross-reactivity in the presence of Ca2+ and 
calmodulin, using monoclonal antibody raised against the rat brain enzyme. In the absence of Ca2+ and 
calmodulin, cross-reactivity of glycogen synthase kinase was decreased, whereas that of calmodulin- 
dependent protein kinase-II was not. The two enzymes appear to represent different isoenzymes of a 
multifunctional calmodulin-dependent protein kinase that may mediate many of the actions of Ca2’ in 
mammalian tissues. The results demonstrate that calmodulin-dependent protein kinase-II is identical to 
calmodulin-dependent synapsin-I kinase-II, previously shown to be very similar to calmodulin-dependent 
glycogen synthase kinase [(1983) FEBS Lett. 163, 329-3341. 
Calmodulin Protein phosphorylation Glycogen synthesis Neurotransmitter 
Catecholamine 
1. INTRODUCTION 
A calmodulin-dependent protein kinase has been 
described that is involved in the activation of tryp- 
tophan 5-monooxygenase, the rate-limiting en- 
zyme in the biosynthesis of serotonin in the brain 
[ 11. This protein kinase was designated 
calmodulin-dependent protein kinase-II [2], since 
it eluted from gel filtration columns after 
phosphorylase kinase (kinase-I) but before myosin 
light chain kinase (kinase-111). However, in con- 
trast to the narrow substrate specificities of 
phosphorylase kinase and myosin light chain 
kinase, kinase-II demonstrated a broad specificity, 
* To whom correspondence should be addressed 
suggesting that it may mediate many of the actions 
of Ca2+ in the central nervous system [2]. 
Recently, a calmodulin-dependent protein 
kinase from skeletal muscle involved in the regula- 
tion of glycogen synthase [3] was compared to a 
calmodulin-dependent protein kinase from brain 
that phosphorylates a major postsynaptic mem- 
brane protein, termed synapsin-I [4,5]. Both en- 
zymes possessed broad and remarkably similar 
substrate specificities and cross-reacted im- 
munologically, while the 58-/60-kDa protein com- 
ponents in these preparations exhibited virtually 
identical ‘phosphopeptide maps’ [5]. 
These findings raised the question of whether 
glycogen synthase kinase and synapsin-I kinase are 
related to kinase-II [6]. We have therefore com- 
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pared the properties of these enzymes in order to 
decide whether a single calmodulin dependent 
multi-protein kinase mediates many of the actions 
of Ca2+ in mammalian tissues. 
2. MATERIALS AND METHODS 
2.1. Protein prepurations 
Calmodulin-dependent glycogen synthase kinase 
was purified from rabbit skeletal muscle [3] and 
calmodulin-dependent protein kinase-II (kinase-II) 
from rat cerebral cortex 171. Calmodulin was 
purified from sheep [8], bovine and rat brain [9] 
and glycogen synthase from rabbit skeletal muscle 
[ 10, 111. Tryptophan S-monooxygenase was par- 
tially purified from rat brain stem 121. This 
preparation was free of kinase-II, but contained 
sufficient amounts of the activator protein re- 
quired to observe activation of tryptophan 
S-monooxygenase after phosphorylation by 
kinase-II (revew [6,12]). Rat brain tubulin was 
purified by chromatography on phosphocellulose 
as in [ 13]. Microtubule-associated protein-2 
(MAP2) was purified by chromatography on Bio- 
Gel A-l .5 m as in [ 141. Myosin light chains were 
purified from chicken gizzard as in [15] or provid- 
ed by Dr J. Kendrick-Jones (MRC Laboratory of 
Molecular Biology, Cambridge, England). 
Synapsin-I from bovine brain [16] was a gift from 
Dr P. Greengard (Rockefeller University, New 
York). Acetyl-CoA carboxylase from lactating rat 
mammary glands and histone H 1 from calf thymus 
were provided by Dr D.G. Hardie (Dept. of 
Biochemistry, University of Dundee, Scotland). 
The sources of other substrate proteins and the 
procedures for their phosphorylation with 
[y-32P]ATP are given in [3]. 
2.2. Activation of tryptophan .5*mono- 
oxygenase (2) 
The standard incubation mixture contained 
50 mM Hepes buffer (pH 7.6), 0.5 mM ATP, 
S mM Mg(CH$00)2, 0.12 mM CaCIt, 0.1 mM -7 
EGTA,~~~nMca%~o?b.ihn, 0.2 mM tryptophan, 
0.3 mM 4-hydroxy-6-methyl-5,6,7,&tetrahydro- 
pteridine, 0.05 mM Fe(NH~)~(SO~)2,2 mM dithio- 
threitol, 50 g catalase, about 0.01 unit of trypto- 
phan 5monooxygenase and a suitable amount of 
kinase-II, in a final volume of 0.2 ml. The incuba- 
50 
tion was carried out at 30°C for 20 min. Units of 
activity are defined in [2]. 
2.3. Preparation of ~onoc~o~a~ antibody to 
kinase-11 and im~a~oprec~pitation of pro fein 
kinases 
Staphylococcus aureus (Cowan I strain) was 
cultured as in [17] and the celIs collected and fixed 
with formaidehyde essentially as in [18]. 
Hybridoma that secrete monoclonal antibody 
(IgM) directed against kinase-II were produced by 
fusion of NS-1 myeloma cells with spleen cells 
from mice that had been immunized with purified 
kinase II essentially as in [19]. 
Immunoprecipitations were carried out by in- 
cubating each protein kinase for 20 min at 4°C 
with varying amounts of monoclonal antibody in a 
solution containing 50 mM Hepes buffer (pH 7.6), 
1 mM dithiothreitol, 1 mg/ml transferrin in the 
presence or absence of 0.2 mM CaCl2 and 3 PM 
calmodulin. The final volume was 25 ~1. Anti- 
mouse IgM (1~1) and a 10% suspension of 
staphylococci (20 ~1) were added, and the mixture 
incubated for 30 min at 4°C with shaking. After 
centrifugation at 20000 x g for 7 min, 30-111 ali- 
quots of the supernatant were withdrawn and 
assayed for enzyme activity, using myosin light 
chains as substrate. 
3. RESULTS 
The substrate specificities of calmodulin- 
dependent glycogen synthase kinase and kinase-II 
are compared in table 1. The specificities of the 
two enzymes were virtually identical. Both protein 
kinases also phosphorylated tubulin and MAP-2, 
the K,,, for the latter substrate being 0.3 PM for 
each enzyme. 
Glycogen synthase is phosphorylated on 7 serine 
residues by at least 6 protein kinases (20-221. The 
calmodulin-dependent glycogen synthase kinase 
phosphorylates two serines, the rapid phosphory- 
lation of site-2 being followed by a slower phos- 
phorylation of site-lb [3]. Glycogen synthase was 
phosphorylated to 0.2 mol/mol subunit with 
kinase-II, digested with cyanogen bromide and 
examined by SDS-polyacrylamide gel electro- 
phoresis as in [21]. This experiment showed that 
180% of the 32P-radioactivity was contained in 
peptide CB-1 (containing site-2) and the remainder 
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Table 1 
Comparison of the substrate specificities of calmodulin-dependent glycogen synthase kinase from 
skeletal muscle (GSK) and kinase-II (KII) from brain 
Substrate Concentration Relative rates of 
phosphorylation ((1Jo) 
Synapsin-I 0.1 1.2 590 620 
Glycogen synthase 0.4 4.6 100 100 
Myosin P-light chain (smooth muscle) 0.8 40.0 76 81 
Histone Hl 0.2 10.0 21 18 
Acetyl-CoA carboxylase 0.11 0.4 8 10 
Phosphorylase b 1.5 15.5 <O.l <O.l 
Phosvitin 2.0 50.0 <O.l <O.l 
Phosphorylation of each protein was carried out as in [3,28) and initial rate conditions were met 
for each substrate 
in CB-2 (containing site-lb). These results were 
identical to those obtained with the calmodulin- 
dependent glycogen synthase kinase [3]. Glycogen 
synthase was then phosphorylated to 0.3 mol/mol 
subunit with kinase-II, digested with trypsin and 
analysed by high performance liquid chromato- 
graphy as in [23]. As shown in fig.lB, the major 
peak of 32P-radioactivity, eluting at 46% aceton- 
(w/ml) VW GSK KII 
t----flJ~20 ii 
10 20 30 LO SO 60 
10 20 30 40 SO 60 
Fig. 1. Separation of tryptic-phosphopeptides from 
glycogen synthase by HPLC. Glycogen synthase was 
phosphorylated to 0.16 mol/mol subunit with skeletal 
muscle calmodulin-dependent glycogen synthase kinase 
(A) or to 0.30 mol/mol subunit with kinase-II (B). The 
enzyme was digested with trypsin (Worthington) and 
analysed on a Waters bondapak Cl8 HPLC column 
(30 cm x 3.9 mm) as in [23]. The column was developed 
with a wateriacetonitrile gradient (- - -) in the presence 
of 0.1% (v/v) trifluoroacetic acid. The flow rate was 
1.0 ml/min, and fractions of 1.0 ml were collected and 
analysed by Cerenkov counting (M). The peptides 
eluting at 23 and 46% acetonitrile correspond to sites-lb 
and 2, respectively [23]. The minor peak at 38% 
acetonitrile is related to site-2, since it is also observed 
after phosphorylating glycogen synthase with either 
phosphorylase kinase or glycogen synthase kinase-4 
tractlon number (unpublished). 
itrile, corresponded to the tryptic peptide contain- 
ing site-2, while the minor peak eluting at 23% 
acetonitrile corresponded to site-lb [23]. Identical 
results were obtained with the calmodulin-depen- 
dent glycogen synthase kinase (fig.lA). No peaks 
corresponding to the positions of the other 5 
known phosphorylation sites [23] were observed. 
Incubation of tryptophan S-monooxygenase 
with kinase-II and Mg-ATP produced the expected 
2-fold activation (fig.2). A similar activation was 
observed when kinase-II was substituted by 
glycogen synthase kinase (fig.2). 
- 
51 
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Fig.2. Activation of tryptophan 5-monooxygenase by 
calmodulin-dependent pro ein kinase-II and calmodulin- 
dependent glycogen synthase kinase. Tryptophan (Trp) 
5-monooxygenase (70 g protein) was incubated with 
different amounts of kinase-II (0) and glycogen 
synthase kinase (0) under the standard conditions (solid 
lines). Control experiments were carried out without 
ATP (broken lines). 
1 I' 
1 
B 
1.0 2.0 0 1.0 2.0 
Antibody lug) Antlbody lugI 
Fig.3. Immunotitration of kinase-II and glycogen 
synthase kinase. Kinase-II (18 ng) (0) and glycogen 
synthase kinase (22 ng) (0) were titrated with the 
indicated amounts of monoclonal antibody prepared 
against kinase-II in the presence (A) or absence (B) of 
Ca2’ and calmodulin as described in section 2. The 
enzyme activity was determined by measuring the 
phosphorylation of smooth muscle myosin light chain 
(1 .O mg/ml). 
52 
Kinase-II and glycogen synthase kinase were rm- 
munotitrated with monoclonal antibody prepared 
against kinase-II. Both protein kinases exhibited 
the same cross-reactivity in the presence of Ca*+ 
and calmodulin (fig.3A). However, in the absence 
of Ca*+ and calmodulin, cross-reactivity of 
glycogen synthase kinase was decreased, whereas 
that of kinase-II remained unchanged (fig.3B). 
4. DISCUSSION 
The present study was prompted by several 
observations that suggested similarities between 
calmodulin-dependent glycogen synthase kinase 
from skeletal muscle and calmodulin-dependent 
protein kinase-II from rat brain. For example, 
although the procedures for isolating these two en- 
zymes [3,7] were developed independently, iden- 
tical steps are employed in their purification 
(although not in the same order). Both enzymes are 
precipitated at < 40% ammonium sulphate, eluted 
from phosphocellulose at 0.28-0.3 M NaCl, and 
have relative molecular masses in excess of 
500 kDa. A close relationship between these two 
protein kinases has now been established by the 
present study. The enzymes have identical 
substrate (table 1) and site (fig.1) specificities and 
cross-react immunologically (fig.3). Differences in 
cross-reactivity were observed in the absence of 
Ca*+ and calmodulin (fig.3B). However, whether 
this reflects a tissue or a species difference remains 
to be elucidated. 
We have demonstrated that calmodulin- 
dependent glycogen synthase kinase from rabbit 
skeletal muscle is closely related to synapsin-I 
kinase-II from rat brain [5]. The present data 
(table 1) therefore suggest hat synapsin-I kinase-II 
and calmodulin-dependent protein kinase-II are 
the same enzyme. This view is reinforced by the 
comigration of these two protein kinases on SDS 
polyacrylamide gels (not shown). Both prepara- 
tions show a minor 60-kDa and a major SO-kDa 
component when electrophoresis is carried out as 
in [24]. However, the apparent molecular mass of 
the major component is 55 kDa when the elec- 
trophoretic system in [25] is employed, as reported 
in [7]. 
Authors in [26] recently examined the substrate 
specificity of synapsin-I kinase-II from rat brain 
and reported that it was unable to use rabbit mus- 
Volume 170, number 1 FEBS LETTERS May 1984 
cle glycogen synthase as substrate. The reason for 
this discrepancy with our own findings ([5] table 1) 
is unclear. However, it could be related to their use 
of commercial glycogen synthase, since we have 
found Sigma glycogen synthase (lot number 
11 lF-9710) to be a much poorer substrate for 
calmodulin-dependent glycogen synthase kinase 
(10% of the rate) than the glycogen synthase 
purified in our laboratory (unpublished). 
Based on the ability of tissue extracts to activate 
tryptophan 5-monooxygenase in the presence of 
Ca’+-calmodulin and Mg-ATP, it was previously 
concluded that calmodulin-dependent protein 
kinase-II kinase was absent from skeletal muscle 
[12,27]. The failure to detect activity appears to be 
due to the buffer used to extract the tissue. After 
inclusion of 50 mM NaCl [28] or 0.1% Triton in 
the homogenisation medium, significant amounts 
of activity are detectable (unpublished). 
A calmodulin-dependent protein kinase active 
towards smooth muscle myosin light chains, 
glycogen synthase and MAP-2 has been purified 
from rat brain by authors in [29-3 11. This enzyme, 
which has a subunit molecular mass of 49 kDa 
[29], is almost certainly identical to synapsin-I 
kinase-IVcalmodulin-dependent protein kinase-II. 
A calmodulin-dependent glycogen synthase kinase 
has been purified from rat liver [32] that is closely 
related to the skeletal muscle enzyme (discussed in 
[3,28]). Recently, the liver preparation has also 
been shown to exhibit a broad specificity and to 
phosphorylate proteins such as synapsin-1 and 
MAP-2 [33]. 
In summary, the present results and those 
presented previously [5,6,33], strengthen the view 
that many of the actions of Ca2+ are mediated by 
a widely distributed multifunctional calmodulin- 
dependent protein kinase. 
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